Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0338671 (Steroids)
 9,479 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Stoll specimens from 3 healthy volunteers were cultured under an-aerobic conditions in brain heart infusion broth with and without the addition of cholate, deoxycholate of chenodeoxycholate. The initial pH of the medium was adjusted to 5.5, 6.3, 7.3 (unadjusted), 8.0, and 9.0. Cell-free extracts prepared from the resulting bacterial growth contained increased levels of NAD- and NADP-dependent 3alpha-, 7alpha-, and 12alpha-hydroxysteroid oxidoreductases when the initial pH was 8.0 or 9.0 and depressed levels of these activities when the initial pH was 5.5 or 6.3 (as compared to control values obtained at 7.3). At pH 5,5 all activities except NAD-dependent 7alpha-hydroxysteroid oxidoreductase were absent. A powerful selective effect was imposed on NAD-dependent 7alpha-hydroxysteroid oxidoreductase when deoxycholate or chenodeoxycholate were incorporated into or chenodeoxycholate were incorporated into the medium. Thin-layer chromatography of either extracts of cholate-containing, acidified spent bacterial medium showed alkaline or neutral (optimal at pH 8). The precent hydroxyl group estimations at the 3alpha-, 7alpha-, and 12alpha-positions revealed an increase in disappearance of OH groups at all three positions with increasing initial pH value. The order of extent of bioconversion was 7alpha-OH greater than 3alpha-OH; at pH 8 AND 9, approximately 90% 7alpha-OH bioconversion was observed. Spent bacterial media and a number of commercial secondary bile salts were all negative in the Ames' assay for mutagenicity.
Steroids 1978 Sep
PMID:Effect of pH on bile salt degradation by mixed fecal cultures. 3 Oct 16

A 3beta-hydroxysteroid dehydrogenase (3betaHSD) was demonstrated in term human fetal membranes (chorion and amnion) with both dehydroepiandrosterone (3beta-hydroxy-5-androsten-17-one) and pregnenolone (3beta-hydroxy-5-pregnen-20-one as substrates, and the subcellular distribution substrate and nucleotide specificity of the enzyme was studied. In both membranes the microsomal fraction (particles which sedimented at 105,000 g after 90 min) had the highest specific activity. The chorion was more active than the amnion but the enzyme in both tissues had similar substrate and nucleotide specificity. NAD was the preferred cofactor, and pregnenolone was a better substrate than dehydroepiandrosterone in the presence of NAD. However, with NADP as cofactor both steroids were equally good substrates. When the 3beta-hydroxysteroid dehydrogenase activity of chorion microsomes was compared with that of placental microsomes, the specific activities were found to be of the same order of magnitude, and the substrate, nucleotide specificity and steroid binding properties were almost identical.
Steroids 1978 Oct
PMID:3beta-Hydroxysteroid dehydrogenase activity in human fetal membranes. 3 Oct 18

The activity of 17 beta-estradiol dehydrogenase (E.C. 1.1.1.62) was measured, and its distribution in the subcellular fractions of bovine placenta was compared. Assay of activity was based on the formation of radioactive estrone from 17 beta[4(-14)C]-estradiol. Either NAD+ or NADP+ can serve as cofactor for the enzyme. The nuclear and microsomal fractions of the placental homogenate exhibited the highest specific enzymatic activities before and after treatment with Triton X-100. Electron micrographs of these two fractions prior to treatment with Triton X-100 showed satisfactory purity. 17 beta-estradiol dehydrogenase from bovine placenta exhibits a pH optimum of about 9.5-10.5, and is activated by 5 x 10(-6)M ZnCl2; comparable concentrations of CaCl2 and MgCl2 inactivate the enzyme. The apparent Michaelis constants, Km, for 17 beta-estradiol and NAD+ are 1.4 x 10(-6)M and 5.5 x 10(-5)M respectively. No 17 alpha-estradiol dehydrogenase activity was demonstrable when using 17 alpha-estradiol as substrate.
Steroids 1979 Aug
PMID:Some characteristics of 17 beta-estradiol dehydrogenase from bovine placenta. 4 Mar 29

In vivo patterns of circulating testosterone (T) were investigated in stock fed controls and parenterally nourished (TPN) rats. Rats were sampled at 2 minute intervals for 30 minutes via a jugular cannula. Both groups exhibited a rapid oscillatory T pattern. In the control group, T concentrations at any specific time interval exhibited large differences with coefficients of variation (17-88%). In TPN rats this variation was 34-79%. Moreover, the mean T concentration of all samples obtained during the 30 minute period for each individual animal ranged from 1.3 +/- 0.1 (S.E.M.) to 3.5 +/- 0.3 (S.E.M.) ng/ml in controls and 1.3 +/- 0.1 (S.E.M.) to 2.0 +/- 0.2 (S.E.M.)ng/ml in controls and 1.3 +/- 0.1 (S.E.M.) to 2.0 +/- 0.2 (S.E.M.) ng/ml for TNP rats respectively. The mean coefficient of variation in control animals, however, was twice that of TPN rats, indicating that variation in basal T may be minimized during intravenous feeding. The occurrence of rapid oscillations in T of both stock and parenterally fed animals shows that nutritional regimen does not affect this phenomenon.
Steroids 1978 Sep
PMID:In vivo patterns of circulating steroids in adult male rats. IV. Evidence for rapid oscillations in testosterone in normal and totally parenterally nourished animals. 10 54

A kinetic analysis of the 5 alpha-reductases from human liver and prostate is presented. Human prostatic 5 alpha-reductase follows an ordered sequential mechanism in which NADPH binds first followed by testosterone. The order of release of products is DHT followed by NADP+. The apparent Km of prostatic 5 alpha-reductase for testosterone is 0.0339 +/- 0.006 microM, while the apparent Km for NADPH is 2.52 +/- 0.65 microM. Human liver 5 alpha-reductase also follows a sequential mechanism. The apparent Km of the liver enzyme is 0.110 +/- 0.08 microM; the apparent Km for NADPH is 6.2 +/- 0.6 microM. The fact that both the liver and prostatic 5 alpha-reductases have a sequential kinetic mechanism rules out the possibility that the reduction of testosterone to dihydrotestosterone involves an electron transport system as previously proposed.
Steroids
PMID:A kinetic analysis of the 5 alpha-reductases from human prostate and liver. 345 48

Flutamide (0.5 mM) decreased in vitro the activity of NADH-5 alpha-reductase (substrate testosterone) in liver homogenate of male and female rats, whereas no change of activity of NADPH-5 alpha-reductase was observed. NADH- and NADPH-5 beta-reductase activity increased only in liver of female, but not of male rats. NAD+-3 beta-hydroxysteroid dehydrogenase and NAD+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 alpha-dihydro-testosterone) in liver homogenate from female rats were inhibited by flutamide (0.5 mM), whereas the activity of NADP+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 alpha-dihydrotestosterone) and of NAD+-3 alpha-hydroxysteroid dehydrogenase (substrate 5 beta-dihydrotestosterone) increased in presence of flutamide. The activity of NADH- and NADPH-5 alpha-reductase decreased after flutamide administration to female rats at a dose of 5 mg per day for 7 days.
Steroids 1987 Jun
PMID:Effect of flutamide on 5 alpha-reductases, 5 beta-reductases, and 3-hydroxysteroid dehydrogenases in rat liver. 348 96

The ability of NADH to function as an alternative cofactor for the support of estrogen biosynthesis was validated. NADH supported rates of aromatization of up to 80% of those obtained with NADPH, with an apparent Km of 0.70 mM, and stimulated the NADPH-supported reaction only when supplies of the normal cofactor were limiting, both additive and synergistic effects being observed. NADH-supported aromatization was inhibited competitively by NADP+ and 2'-AMP with Ki values of 5 microM and 22 microM, respectively. Support by both cofactors was lost in parallel with the selective removal of NADPH-cytochrome c reductase from microsomes by graded subtilisin treatment. NADH-supported aromatization was differentiated from NADPH-supported aromatization by its sensitivity to inhibition by NAD+ and its response to changes in ionic strength. NADH appears to function, at high concentrations, as a surrogate for NADPH at the reduced nucleotide-binding site of NADPH-cytochrome c reductase but additional roles for NADH are also suggested both when acting alone and as a supplement to NADPH. A common oxidase (cytochrome P-450) appears to catalyze both NADH- and NADPH-supported aromatization.
Steroids 1983 Jul
PMID:The roles of NADH in the support of steroid aromatization by human placental microsomes. 642 72

Recent kinetic studies on the placental microsomal 3 beta-hydroxysteroid dehydrogenase have shown that apparent Km values for 3 beta-hydroxy-5-androsten-17-one (dehydroepiandrosterone) and 3 beta-hydroxy-5-pregnen-20-one (pregnenolone) are 15nM and 40nM respectively, which are orders of magnitude lower than found in earlier studies. The purpose of this study was to investigate the substrate and nucleotide specificity of the 3 beta-hydroxysteroid dehydrogenase, and the ability of various steroids to inhibit the reaction at these lower steroid concentrations. Each steroid inhibited the metabolism of the other competitively, and the Ki values obtained were not significantly different from their respective Km values. The ability of various steroids to inhibit the reaction at concentrations of 100nM was usually less than that found at micromolar concentrations. However, certain steroids showed marked inhibition. For example, estrone and estradiol-17 beta inhibit the oxidation of both substrates competitively with Ki values of between 15 and 24nM. The Km values of dehydroepiandrosterone and pregnenolone with NADP+ as cofactor are higher than those with NAD+ as cofactor and the V values are much lower. These data indicate that in human placental microsomes a single 3 beta-hydroxysteroid dehydrogenase, essentially NAD+ specific, metabolizes dehydroepiandrosterone and pregnenolone.
Steroids 1981 Jan
PMID:Substrate and nucleotide specificity of placental microsomal 3 beta-hydroxysteroid dehydrogenase. 645 19

To further characterize 17 beta-hydroxysteroid dehydrogenase (17 beta-SDH) from cultured ovine myometrial cells, an assay was established in whole cell homogenates and cell subfractions. Tritiated estradiol (E2) was incubated in the presence of an excess of cofactor and estrone (E1) formed purified by thin-layer chromatography. The enzyme activity was linear with time up to 2 hours and with protein concentration up to 0.7 mg/ml at the substrate concentration used (5 X 10(-9) M). The routine assay was for 30 min in the presence of 0.5 mg/ml of protein. Both NAD+ or NADP+ could sustain enzyme activity but NAD+ was twice as much efficient. Most of the enzyme activity was associated with the microsome and mitochondrial membranes. The addition of an excess (1000 microM) of NAD+ to the incubation medium prevented the progressive decline observed with time in a given subculture in the intact cell monolayer assay, supporting our previous hypothesis that this decline was due to cofactor depletion. In contrast, the slow and irreversible decline of enzyme activity observed in successive subcultures was not prevented by the addition of cofactor to the homogenate and thus reflects another phenomenon, probably a change in metabolism with age.
Steroids 1983 Nov
PMID:Further characterization of 17 beta-hydroxysteroid dehydrogenase activity in cultured myometrial cells: cofactor dependency and subcellular localization. 659 56

The kinetics of 11 beta-hydroxysteroid dehydrogenase (11HSD) catalyzing the interconversion of cortisol (F) and cortisone (E) were compared in vitro following incubation of homogenates of human (N = 7) and baboon (N = 2) placenta. In both species, enzyme activity catalyzing the conversion of F to E was associated with the membrane fraction of the cell, was greater in the presence of NAD+ than NADP+, was of similar concentration within the placenta, and exhibited a similar Km for F. Moreover, there was no conversion of E to F in either the baboon or human placenta indicating that in both species, term placenta lacks the 11HSD enzyme catalyzing the reduction of the 11-oxo group of corticosteroids. Significantly, the conversion of F to E by both the baboon and human placenta was inhibited when progesterone was added to the reaction mixture at concentrations equimolar to the substrate. We conclude that 11HSD enzyme kinetics in term baboon placental homogenates are similar to those measured in human term placenta. Moreover, progesterone may be a physiologic regulator of 11HSD in both the human and baboon placenta. Collectively, our findings support the use of the baboon as a model for studies of the regulation of placental corticosteroid metabolism during human pregnancy.
Steroids 1984 Sep
PMID:Comparison of cortisol-cortisone interconversion in vitro by the human and baboon placenta. 659 30


1 2 3 4 Next >>